Where does Express Scripts Strategic Development, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Express Scripts Strategic Development, Inc. ranks #1,307 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Express Scripts Strategic Development, Inc. hold?

Express Scripts Strategic Development, Inc. holds 324 US utility patents granted between 2017 and 2025, spanning 55 technology areas.

What is Express Scripts Strategic Development, Inc.'s Innovation Score?

Express Scripts Strategic Development, Inc. has an Innovation Score of 68.4 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Express Scripts Strategic Development, Inc.'s patent grant rate increasing or decreasing?

Express Scripts Strategic Development, Inc.'s recent grant velocity is +470% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Express Scripts Strategic Development, Inc.'s patents?

Express Scripts Strategic Development, Inc.'s patents average 17.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView US Corporation

Express Scripts Strategic Development, Inc.

Q: What technology areas does Express Scripts Strategic Development, Inc. focus on?

Express Scripts Strategic Development, Inc.'s top technology area is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data) with 157 patents, ranking #26 of 3,149 assignees active in that subclass. Grants appear in 55 CPC subclasses total.

Q: How is the Express Scripts Strategic Development, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 324 granted patents across 55 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Express ranks #1,307 of 49,997 tracked US assignees by granted-patent volume, with 324 patents across 55 technology areas.

#1,307
of 49,997 US assignees by volume: Top 1%
by Innovation Score (68.4/100): 17.9
avg claims per patent: +470%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1307 · US Corporation #1,307 · 324 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 324 grants
TOP-DECILE #1,307/49,997
PHOTO-FINISH Ablic
CPC-WIDE G16H · 55 areas
INNOV-STRONG 68.4/100
CLAIMS-RICH 17.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +470% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ablic Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Express’s 68.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 20.0 pts (29%) Velocity 12.6 pts (18%) Breadth 25.0 pts (37%) Claim depth 10.8 pts (16%)

Qualcomm Incorporated · highest

85
California Institute… · near

68
Express Scripts… · this assignee

68
Imperial College… · near

68
Baker Hughes Holdings · near

68
Enevate · near

68
3D Lighting… · lowest

7

What this shows Express's Innovation Score is 68.4/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Express?

Each dot is one of Express’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Express’s own 17.9 claims/patent is ABOVE the 17.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Express vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Express's grant cadence moved

Between 2020–2024, Express Scripts Strategic Development, Inc. received 251 grants versus 44 in 2015–2019 (+470% equal-window velocity, top decile growth). Across complete PatentsView years, output peaked in 2023 at 68 grants and bottomed in 2017 at 1. Lead class G16H accounts for 48.5% of the portfolio across 55 subclasses. Volume neighbours: Chugai Seiyaku Kabushiki Kaisha (#1,303) and Virginia Tech Intellectual Properties, Inc. (#1,311).

Express's three-year grant acceleration

From 2019–2021 to 2022–2024, Express Scripts Strategic Development, Inc. moved from 95 to 180 grants (1.90x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #241. See the growth leaderboard.

Chugai Seiyaku

325
Continental Reife…

325
Sony Interactive…

325
Ablic

324
PFU

324
The Hong Kong Uni…

324
UAB 360 IT

324
Virginia Tech Int…

324
Express Scripts S… ◀

324

What this shows Express holds 324 patents at rank #1,307, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Express

By rank, the assignees closest to #1,307 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Express's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Express, neither rank-band nor same-CPC leaders (those blocks stay above). In G16H (Healthcare Informatics), Express ranks #26 of 3,149 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (68 here).

California Institute OF Technology 68 Imperial College Innovations Ltd 68 Enevate Corporation 68 Baker Hughes Holdings LLC 68

Similar claim depth

Nearest assignees by average claims per patent (17.9 here).

Business Objects Software Ltd. 17.9 avg Magna Closures Inc. 17.9 avg THE UAB Research Foundation 17.9 avg Beijing Bytedance Network Technology Co., Ltd. 17.9 avg

Express's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

68 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Express Scripts Strategic Development, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	0.3%
2018	19	5.9%
2019	24	7.4%
2020	39	12.0%
2021	32	9.9%
2022	63	19.4%
2023	68	21.0%
2024	49	15.1%
2025partial year	29	9.0%

Which technologies does Express Scripts Strategic Development, Inc. patent most?

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 157

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 131

G06F - Electric Digital Data Processing 96

G06N - Computing Arrangements Based ON Specific Computational Models 56

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 49

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 40

B65G - Transport OR Storage Devices, e.g. Conveyors FOR Loading OR Tipping, Shop Conveyor Systems OR Pneumatic Tube Conveyors 35

G07F - Coin-freed OR Like Apparatus 30

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 22

G10L - Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding 18

H04M - Telephonic Communication 18

G06K - Graphical Data Reading ; Presentation OF DATA; Record CARRIERS; Handling Record Carriers 16

G06T - Image Data Processing OR Generation, IN General 14

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 14

B64U - Unmanned Aerial Vehicles [UAV]; Equipment Therefor 14

Top 15 of 55 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Express Scripts Strategic Development, Inc.'s patent record in context - here's where to go next.

Express Scripts Strategic Development, Inc.'s lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 48.5% of its portfolio - see every assignee active in that class. Explore G16H
Ranked #1,307 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Express Scripts Strategic Development, Inc. against Chugai Seiyaku Kabushiki Kaisha, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 68.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.